CINECA IRIS Institutional Research Information System

LEO, MARENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.176
AS - Asia 1.152
EU - Europa 1.142
SA - Sud America 147
AF - Africa 76
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.102
SG - Singapore 363
CN - Cina 338
SE - Svezia 287
IT - Italia 225
HK - Hong Kong 201
DE - Germania 149
BR - Brasile 116
GB - Regno Unito 97
VN - Vietnam 95
BG - Bulgaria 92
FR - Francia 89
CA - Canada 54
AT - Austria 45
FI - Finlandia 40
CI - Costa d'Avorio 39
IN - India 39
RU - Federazione Russa 37
TR - Turchia 35
JP - Giappone 20
SN - Senegal 20
UA - Ucraina 18
BE - Belgio 14
NL - Olanda 14
AR - Argentina 12
BD - Bangladesh 11
MX - Messico 9
PL - Polonia 8
SA - Arabia Saudita 8
IQ - Iraq 7
PH - Filippine 7
PK - Pakistan 7
ES - Italia 6
VE - Venezuela 6
UZ - Uzbekistan 5
IE - Irlanda 4
ZA - Sudafrica 4
AU - Australia 3
AZ - Azerbaigian 3
CR - Costa Rica 3
EC - Ecuador 3
EG - Egitto 3
EU - Europa 3
ID - Indonesia 3
LT - Lituania 3
MA - Marocco 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BS - Bahamas 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
PE - Perù 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.699
Salva come PNG Salva come JPEG
Città #
Ashburn 331
Fairfield 288
Woodbridge 286
Houston 266
Ann Arbor 234
Hong Kong 196
Singapore 181
Dallas 175
Santa Clara 163
Chandler 158
Seattle 136
San Jose 132
Wilmington 103
Sofia 92
Cambridge 85
Beijing 80
Shanghai 76
New York 68
Serra 67
Los Angeles 57
Munich 43
Vienna 43
London 41
Boardman 40
Abidjan 39
Ottawa 37
Princeton 37
Lawrence 31
Medford 29
Bremen 26
Lauterbourg 25
Frankfurt am Main 24
Lancaster 24
Nanjing 24
Des Moines 23
Florence 23
Dakar 20
Ho Chi Minh City 20
Dong Ket 18
Istanbul 17
Marseille 17
Redondo Beach 16
Rome 16
Dearborn 15
Ogden 15
Tokyo 15
Brussels 14
Hanoi 14
Milan 13
Turku 13
Fuzhou 12
Chicago 11
Orem 11
Pisa 11
Buffalo 10
Nanchang 10
San Diego 10
Toronto 10
Falls Church 9
Izmir 9
Jacksonville 9
Chennai 8
Hebei 8
Atlanta 7
Council Bluffs 7
Düsseldorf 7
Helsinki 7
Houten 7
Manchester 7
Warsaw 7
Da Nang 6
Guangzhou 6
Kunming 6
Phoenix 6
Poplar 6
São Paulo 6
Brooklyn 5
Changsha 5
Columbus 5
San Francisco 5
Stockholm 5
Tashkent 5
The Dalles 5
Tianjin 5
Ankara 4
Aosta 4
Jüchen 4
Kent 4
Ossé 4
Portsmouth 4
Rio de Janeiro 4
Riyadh 4
Baghdad 3
Baku 3
Boulder 3
Denver 3
Elk Grove Village 3
Hangzhou 3
Hefei 3
Jeddah 3
Totale 4.215
Salva come PNG Salva come JPEG
Nome #
Natural history of graves’ orbitopathy after treatment 265
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 243
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 219
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 214
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 203
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 200
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 190
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 184
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 183
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 174
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 173
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 171
Thyroid volume and severity of graves' orbitopathy 157
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 156
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 152
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 151
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 148
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 148
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 142
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 142
Treatment options for Graves' orbitopathy. 134
Selenium in Graves Hyperthyroidism and Orbitopathy 132
null 121
null 120
Oxidative stress in graves' disease. 118
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 109
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 107
null 97
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 96
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 94
null 93
null 91
null 88
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 86
null 85
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 77
null 65
Total thyroid ablation in Graves' orbitopathy 49
Totale 5.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023613 64 119 54 51 46 67 6 48 118 0 37 3
2023/2024269 13 20 31 5 30 71 7 20 4 3 37 28
2024/20251.078 7 34 9 65 132 120 69 41 129 139 103 230
2025/20261.272 117 145 151 104 151 93 195 65 64 106 61 20
Totale 5.789